Author:
Kifle Mearg Eyasu,Aychiluhm Setognal Birara,Anbesu Etsay Woldu
Abstract
Abstract
Background
During the coronavirus pandemic, people faced strict preventive measures, including staying at home and maintaining social distance, which led to increasing rates of intimate partner violence. Women have been facing dual health emergencies, including COVID-19 and domestic violence. Despite this, there is a lack of representative data on intimate partner violence during the COVID-19 pandemic and inconsistent findings.
Methods
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were used to develop the systematic review and meta-analysis. All English-language studies conducted between 31 December 2019 and May 15/2022 were extracted from databases such as PubMed/Medline, CINAHL, and Google Scholar. The quality of the articles was assessed using the Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI). The I2 was used to assess heterogeneity among studies. Publication bias was assessed using funnel plot inspection and Egger’s test. A random effect model was used for the analysis using RevMan and STATA 14 software.
Result
A total of 5065 studies were retrieved, and 14 studies were included in the final meta-analysis. The pooled prevalence of intimate partner violence was 31% (95% CI: 22, 40). Subgroup analysis based on region showed that the highest prevalence of intimate partner violence was in developing regions (33, 95% CI: 23.0, 43.0) compared to developed regions (14, 95% CI: 11.0, 17.0). Subgroup analysis based on country showed that Uganda had the highest prevalence of IPV 68% (95% CI: 62.0, 72.0), and the lowest was in the USA 10% (95% CI: 7.0, 15.0).
Conclusion
Nearly one in three women experienced intimate partner violence during the COVID-19 pandemic. Subgroup analysis based on region showed that the highest prevalence of intimate partner violence was in developing regions (33%). All forms of intimate partner violence (physical, sexual, emotional, and economic) were prevalent. Thus, available interventions should be implemented to alleviate women’s intimate partner violence during the COVID-19 pandemic and similar emerging and remerging pandemics, particularly in developing countries.
Trial registration
PROSPERO registration number: CRD42022334613.
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Goldfarb S, Goldscheid J. International human rights law on violence against women and children and its impact on domestic law and action. In: Women and children as victims and offenders: background, prevention, reintegration. Springer; 2016. p. 3–45.
2. Russo NF, Pirlott A. Gender-based violence: concepts, methods, and findings. Ann N Y Acad Sci. 2006;1087(1):178–205.
3. Hossain M, McAlpine A. Gender based violence research methodologies in humanitarian settings: an evidence review and recommendations; 2017.
4. Ehitemariyam T. Assessment of intimate partner violence against women of reproductive age and associated factors during covid 19 pandemic in Debre Berhan Town, Ethiopia 2021: a community–based cross-sectional study 2021.
5. Garcia-Moreno C, Jansen HAFM, Ellsberg M, Heise L, Watts C. WHO multicountry study on women’s health and domestic violence against women: initial results on prevalence, health outcomes and women’s responses. Geneva: World Health Organization; 2005.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献